BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 16698035)

  • 1. ACCA phosphopeptide recognition by the BRCT repeats of BRCA1.
    Ray H; Moreau K; Dizin E; Callebaut I; Venezia ND
    J Mol Biol; 2006 Jun; 359(4):973-82. PubMed ID: 16698035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT domains.
    Magnard C; Bachelier R; Vincent A; Jaquinod M; Kieffer S; Lenoir GM; Venezia ND
    Oncogene; 2002 Oct; 21(44):6729-39. PubMed ID: 12360400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell cycle regulation of the BRCA1/acetyl-CoA-carboxylase complex.
    Ray H; Suau F; Vincent A; Dalla Venezia N
    Biochem Biophys Res Commun; 2009 Jan; 378(3):615-9. PubMed ID: 19061860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of phosphopeptide recognition by the BRCT domain of BRCA1.
    Williams RS; Lee MS; Hau DD; Glover JN
    Nat Struct Mol Biol; 2004 Jun; 11(6):519-25. PubMed ID: 15133503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BRCA1 and acetyl-CoA carboxylase: the metabolic syndrome of breast cancer.
    Brunet J; Vazquez-Martin A; Colomer R; Graña-Suarez B; Martin-Castillo B; Menendez JA
    Mol Carcinog; 2008 Feb; 47(2):157-63. PubMed ID: 17620310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the BRCT repeat region from the breast cancer-associated protein BRCA1.
    Williams RS; Green R; Glover JN
    Nat Struct Biol; 2001 Oct; 8(10):838-42. PubMed ID: 11573086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions between BRCT repeats and phosphoproteins: tangled up in two.
    Glover JN; Williams RS; Lee MS
    Trends Biochem Sci; 2004 Nov; 29(11):579-85. PubMed ID: 15501676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thermal denaturation of the BRCT tandem repeat region of human tumour suppressor gene product BRCA1.
    Pyrpassopoulos S; Ladopoulou A; Vlassi M; Papanikolau Y; Vorgias CE; Yannoukakos D; Nounesis G
    Biophys Chem; 2005 Apr; 114(1):1-12. PubMed ID: 15792855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The BRCT domain is a phospho-protein binding domain.
    Yu X; Chini CC; He M; Mer G; Chen J
    Science; 2003 Oct; 302(5645):639-42. PubMed ID: 14576433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRCA1 affects lipid synthesis through its interaction with acetyl-CoA carboxylase.
    Moreau K; Dizin E; Ray H; Luquain C; Lefai E; Foufelle F; Billaud M; Lenoir GM; Venezia ND
    J Biol Chem; 2006 Feb; 281(6):3172-81. PubMed ID: 16326698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and mechanism of BRCA1 BRCT domain recognition of phosphorylated BACH1 with implications for cancer.
    Clapperton JA; Manke IA; Lowery DM; Ho T; Haire LF; Yaffe MB; Smerdon SJ
    Nat Struct Mol Biol; 2004 Jun; 11(6):512-8. PubMed ID: 15133502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of cancer-linked BRCA1-BRCT missense variants and their interaction with phosphoprotein targets.
    Drikos I; Nounesis G; Vorgias CE
    Proteins; 2009 Nov; 77(2):464-76. PubMed ID: 19452558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution structure, backbone dynamics, and association behavior of the C-terminal BRCT domain from the breast cancer-associated protein BRCA1.
    Gaiser OJ; Ball LJ; Schmieder P; Leitner D; Strauss H; Wahl M; Kühne R; Oschkinat H; Heinemann U
    Biochemistry; 2004 Dec; 43(51):15983-95. PubMed ID: 15609993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-throughput fluorescence polarization assay to identify small molecule inhibitors of BRCT domains of breast cancer gene 1.
    Lokesh GL; Rachamallu A; Kumar GD; Natarajan A
    Anal Biochem; 2006 May; 352(1):135-41. PubMed ID: 16500609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of the BRCT repeats of BRCA1 bound to a BACH1 phosphopeptide: implications for signaling.
    Shiozaki EN; Gu L; Yan N; Shi Y
    Mol Cell; 2004 May; 14(3):405-12. PubMed ID: 15125843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-related mutations in BRCA1-BRCT cause long-range structural changes in protein-protein binding sites: a molecular dynamics study.
    Gough CA; Gojobori T; Imanishi T
    Proteins; 2007 Jan; 66(1):69-86. PubMed ID: 17063491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of ATR-interacting protein on Ser239 mediates an interaction with breast-ovarian cancer susceptibility 1 and checkpoint function.
    Venere M; Snyder A; Zgheib O; Halazonetis TD
    Cancer Res; 2007 Jul; 67(13):6100-5. PubMed ID: 17616665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for phosphorylation-dependent signaling in the DNA-damage response.
    Williams RS; Bernstein N; Lee MS; Rakovszky ML; Cui D; Green R; Weinfeld M; Glover JN
    Biochem Cell Biol; 2005 Dec; 83(6):721-7. PubMed ID: 16333323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Missense mutations of BRCA1 gene affect the binding with p53 both in vitro and in vivo.
    Quaresima B; Faniello MC; Baudi F; Crugliano T; Di Sanzo M; Cuda G; Costanzo F; Venuta S
    Oncol Rep; 2006 Oct; 16(4):811-5. PubMed ID: 16969499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cloning, expression and transcriptional analysis of biotin carboxyl carrier protein gene (accA) from Amycolatopsis mediterranei U32 ].
    Lu J; Yao Y; Jiang W; Jiao R
    Wei Sheng Wu Xue Bao; 2003 Feb; 43(1):56-64. PubMed ID: 16276872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.